Strategic update on the progress and development of Molecure's key clinical projects in 2024
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and ...
Cutting Medicaid could worsen overdose deaths — and erase recent progress in treating addiction
Reducing funding to the largest payer for addiction services could pose major setbacks for those battling drug use ...
MyChesCo on MSN1d
Mineralys Therapeutics to Host Webinar on Lorundsrostat and Hypertension Treatment Progress
RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced an upcoming conference call and webinar to highlight ...
CURE4d
Aligning Treatment Goals: Key Considerations for Patients and Caregivers in Late-Line RRMM
Panelists discuss how quality of life priorities shift in late-line multiple myeloma treatment, with patients emphasizing the ...
CURE2d
Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma
A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral ...